Target intelligence / Profile preview

Multiple pro-inflammatory cytokines and cellular proliferation pathways

Molecular classification
Other (Cytokines are a broad class of small secreted proteins, not a single molecule or receptor), Receptor (for the receptors that bind these cytokines), Enzyme (for some downstream signaling components), Transcription factor (for some downstream effectors)
01

Overview

"Multiple pro-inflammatory cytokines and cellular proliferation pathways" is not a single molecular target but rather refers collectively to a diverse set of small secreted proteins—primarily interleukins (such as IL‑1, IL‑6), tumor necrosis factors (TNF-alpha), interferons—and their associated signaling cascades that regulate immune cell activation, differentiation, growth, migration (“homing”), and inflammatory responses. These molecules act through various structurally distinct receptors on immune cells and other tissues throughout the body. They play central roles in orchestrating both acute defense against pathogens and chronic inflammatory processes implicated in autoimmune diseases, cancer progression via promotion of cell survival/proliferation signals, bone resorption disorders (“osteoimmunology”), sepsis/cytokine storms during severe infections like COVID‑19,[1][2][3] among others. Because this term encompasses many different targets rather than one discrete protein/receptor/gene product,[2] it is considered too broad/unspecific for use as a canonical therapeutic target name. This entry is flagged is_incorrect: true because "Multiple pro-inflammatory cytokines/cellular proliferation pathways" does not refer to any one canonical molecule/receptor/target but instead describes an entire functional category spanning numerous distinct proteins/pathways.[2] For structured data purposes you should map this entry into its constituent canonical targets where possible—such as “Interleukin 6”, “Tumor necrosis factor alpha”, etc.—rather than treat it as a single entity.

Other names
Pro-inflammatory cytokinesCellular proliferation pathwaysInflammatory cytokine signalingCytokine storm mediators
02

Mechanism of action

Drugs targeting these molecules act via mechanisms such as: Neutralization of specific cytokines by monoclonal antibodies or receptor antagonists; Blockade of cell surface receptors for key pro-inflammatory cytokines; Inhibition of intracellular signal transduction pathways involved in cellular proliferation and inflammation.

03

Biological functions

Immune responseInflammation regulationCell activation and differentiationCell proliferationSignal transduction
04

Disease associations

InflammationCancerAutoimmune diseaseInfection
05

Safety considerations

immunosuppression with increased risk of infectionoff-target effects may also disrupt normal immune surveillance leading to malignancy risk or impaired tissue repairOver-inhibition can cause adverse events such as cytopenias or liver dysfunction
06

Interacting drugs

Monoclonal antibodies against TNF-alpha (e.g., infliximab, adalimumab)

2 more in the full profile.

07

Biomarkers

elevated serum levels of specific pro-inflammatory cytokines such as IL‑6TNF-alphaCRP

Beyond the preview

Go deeper on Multiple pro-inflammatory cytokines and cellular proliferation pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple pro-inflammatory cytokines and cellular proliferation pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call